Prospects for development of a transmission blocking vaccine against Schistosoma japonicum

Parasite Immunology

Volumn 27, Issue 7-8, 2005, Pages 297-308

  McManus, D P ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Antigen discovery; Schistosoma japonicum; Schistosomiasis japonica; Transmission blocking veterinary vaccine

Indexed keywords

PRAZIQUANTEL; SCHISTOSOMA VACCINE;

CHINA; DISEASE TRANSMISSION; GENOMICS; HUMAN; IMMUNE SYSTEM; INFECTION CONTROL; MATHEMATICAL MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE IDENTIFICATION; PHILIPPINES; PRIORITY JOURNAL; REVIEW; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; UNINDEXED SEQUENCE; VACCINE PRODUCTION;

ANIMALS; ANTIGENS, HELMINTH; CATTLE; CATTLE DISEASES; HUMANS; MICE; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; VACCINATION; VACCINES, DNA;

BOVINAE; BUBALUS BUBALIS; SCHISTOSOMA; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA;

EID: 25144473971     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2005.00784.x     Document Type: Review

References (84)

1. Chen MG & Feng Z. Schistosomiasis control in China. Parasitol Int 1999; 48: 11-19.
2. Blas BL, Rosales MI, Lipayon IL et al. The schistosomiasis problem in the Philippines: a review. Parasitol Int 2004; 53: 127-134.
3. Ross AGP, Sleigh AC, Li Y et al. Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st Century. Clin Micro Rev 2001; 14: 270-295.
4. Ross AGP, Bartley PB, Sleigh AC et al. Schistosomiasis. New Engl J Med 2002; 346: 1212-1220.
5. King CH, Dickman K & Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005; 365: 1561-1569.
6. Guyatt H. The cost of delivering and sustaining a control programme for schistosomiasis and soil-transmitted helminthiasis. Acta Trop 2003; 86: 267-274.
7. Todd C & Colley D. Practical and ethical issues in the development of a vaccine against schistosomiasis mansoni. Am J Trop Med Hyg 2002; 66: 348-358.
8. Williams GM, Sleigh AC, Li YS et al. Mathematical modelling of Schistosoma japonica: comparison of control strategies in the People's Republic of China. Acta Trop 2002; 2: 253-262.
9. Shi F, Zhang Y, Ye P et al. Laboratory and field evaluation of Schistosoma japonicum DNA vaccines in sheep and water buffalo in China. Vaccine 2001; 20: 462-467.
10. He YK, Liu SX, Zhang XY et al. Field assessment of recombinant Schistosoma japonicum 26 kDa glutathione S-transferase in Chinese water buffaloes. Southeast Asian J Trop Med Public Health 2003; 34: 473-479.
11. Zhu Y, Ren J, Da'dara A et al. The protective effect of a Schistosoma japonicum Chinese strain 23 kDa plasmid DNA vaccine in pigs is enhanced with IL-12. Vaccine 2004; 15 (23): 78-83.
12. Chen HA & Lin D. The prevalence and control of schistosomiasis in Poyang Lake region, China. Parasitol Int 2004; 53: 115-125.
13. Guo JG, Ross AGP, Lin DD et al. A baseline study on the importance of bovines for human Schistosoma japonicum infection around Poyang Lake, China. Am J Trop Med Hyg 2001; 65: 272-278.
14. Bergquist NR, Leonardo LR & Mitchell GF. Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? Trends Parasitol 2005; 21: 112-117.
15. Capron A. Schistosomiasis: forty years' war on the worm. Parasitol Today 1998; 14: 379-384.
16. Capron A, Riveau G, Capron M & Trottein F. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol 2005; 21: 143-149.
17. Ross AGP, Sleigh AC, Li YS, Williams GM, Aligui GDL & McManus DP. Is there immunity to Schistosoma japonicum?. Parasitol Today 2000; 16: 159-164.
18. Hagan P, Blumenthal UJ, Dunn D, Simpson AJG & Wilkins HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991; 349: 243-245.
19. Demeure CE, Rihet P, Abel L et al. Resistance to S. mansoni in humans: influence of IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infect Dis 1993; 168: 1000-1008.
20. Grzych JM, Grezel D, Xu CB et al. IgA antibodies to a protective antigen in human schistosomiasis mansoni. J Immunol 1993; 150: 527-635.
21. Dunne DW, Hagan P & Abath FGC. Prospects for immunological control of schistosomiasis. Lancet 1995; 345: 1488-1492.
22. McManus DP. The search for a vaccine against schistosomiasis - a difficult path but an achievable goal. Immunol Rev 1999; 171: 149-161.
23. Acosta LP, Waine G, Aligui GD et al. Immune correlate study on human Schistosoma japonicum in a well-defined population in Leyte, Philippines. II. Cellular immune responses to S. japonicum recombinant and native antigens. Acta Trop 2002; 84: 137-149.
24. Acosta LP, McManus DP, Aligui GD, Olveda RM & Tiu WU. Antigen-specific antibody isotype patterns to Schistosoma japonicum recombinant and native antigens in a defined population in Leyte, the Philippines. Am J Trop Med Hyg 2004; 70: 549-555.
25. Joseph S, Jones FM, Kimani G et al. Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for Schistosoma mansoni in Uganda: the differential effect of parasite worm and egg antigens. Infect Immun 2004; 72: 728-734.
26. De Bont J & Vercruysse J. Schistosomiasis in cattle. Adv Parasitol 1998; 41: 285-364.
27. Capron A, Riveau GJ, Hartley PB & McManus DP. Prospects for a schistosome vaccine. Curr Drug Targets Immune Endocr Metabol Disord 2002; 2: 281-290.
28. Hoffmann KF, Wynn TA & Dunne DW. Cytokine-mediated host responses during schistosome infections; walking the fine line between immunological control and immunopathology. Adv Parasitol 2002; 52: 265-307.
29. Pearce EJ & MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol 2002; 2: 499-511.
30. Capron A, Riveau GJ, Hartley PB & McManus DP. Vaccines against schistosomiasis. In New Generation Vaccines, 3rd edn, eds Levine MM, Kaper JB, Rappuoli R, Liu M, Good, M. New York and Basel: Marcel Dekker, Inc.; 2003: 915-925.
31. Capron A, Riveau G, Capron M & Trottein F. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol 2005; 21: 143-149.
32. Pearce EJ. Progress towards a vaccine for schistosomiasis. Acta Trop 2003; 86: 309-313.
33. Hagan P & Sharaf O. Schistosomiasis vaccines. Expert Opin Biol Ther 2003; 3: 1271-1278.
34. McManus DP & Bartley PB. A vaccine against Asian schistosomiasis. Parasitol Int 2004; 53: 163-173.
35. Lebens M, Sun JB, Czerkinsky C & Holmgren J. Current status and future prospects for a vaccine against schistosomiasis. Expert Rev Vaccines 2004; 3: 315-328.
36. Shi YE, Jiang CF, Han JJ, Li YL & Ruppel A. Schistosoma japonicum: an ultraviolet-attenuated cercarial vaccine applicable in the field for water buffaloes. Exp Parasitol 1990; 71: 100-106.
37. Zhang Y, Taylor MG, Bickle QD, Wang H & Ge J. Vaccination of mice with gamma-irradiated Schistosoma japonicum cercariae. Parasite Immunol 1999; 21: 111-117.
38. Bergquist NR, Al-Sherbiny M, Barakat R & Olds R. Blueprint for schistosomiasis vaccine development. Acta Trop 2002; 82: 183-192.
39. Gobert GN & McManus DP. Update on paramyosin in parasitic worms. Parasitol Int 2005; 54: 101-107.
40. Loukas A, Jones M, King L, Brindley P & McManus DP. Receptor for Fc on the surfaces of schistosomes. Infect Immun 2001; 69: 3646-3651.
41. Deng J, Gold D, LoVerde PT & Fishelson Z. Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin. Infect Immun 2003; 71: 6402-6410.
42. Ramirez BL, Kurtis JD, Wiest PM et al. Paramyosin: a candidate vaccine antigen against Schistosoma japonicum. Parasite Immunol 1996; 18: 49-52.
43. McManus DP, Wong JY, Zhou J et al. Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes, Vaccine 2001; 20: 870-878.
44. Taylor MG, Huggins MC, Shi F et al. Production and testing of Schistosoma japonicum candidate vaccine antigens in the natural ovine host. Vaccine 1998; 16: 1290-1298.
45. Chen H, Nara T, Zeng X et al. Vaccination of domestic pig with recombinant paramyosin. against Schistosoma japonicum in China. Vaccine 2000; 18: 2142-2146.
46. Zhang D, Pan W, Qian L et al. Investigation of recombinant Schistosoma japonicum paramyosin fragments for immuno-genicity and vaccine efficacy in mice. Parasite Immunol, in press.
47. Zhang R, Yoshida A, Kumagai T et al. Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum. Infect Immun 2001; 69: 386-391.
48. Kumagai T, Maruyama H, Hato M et al. Schistosoma japonicum: localization of calpain in the penetration glands and secretions of cercariae. Exp Parasitol 2005; 109: 53-57.
49. Ohta N, Kumagai T, Maruyama H, Yoshida A, He Y & Zhang R. Research on calpain of Schistosoma japonicum as a vaccine candidate. Parasitol Int 2004; 53: 175-181.
50. Osada Y, Kumagai T, Hato M et al. Establishment of Schistosoma japonicum calpain-specific mouse T cell hybridomas and identification of a T cell epitope that stimulates IFNgamma production. Vaccine 2005; 23: 2813-2819.
51. Li Y, Auliff A, Jones M, Yi X & McManus DP. Immunogenicity and immunolocalization of the 22.6 kDa antigen of Schistosoma japonicum. Parasite Immunol 2000; 22: 415-424.
52. Verity C, McManus DP & Brindley PJ. Developmental expression of cathepsin D aspartic protease in Schistosoma japonicum. Int J Parasitol 1999; 29: 1819-1824.
53. Verity C, McManus DP & Brindley PJ. Vaccine efficacy of recombinant cathepsin D aspartic protease from Schistosoma japonicum. Parasite Immunol 2001; 23: 153-162.
54. Verity C, McManus DP & Brindley PJ. Cellular responses to Schistosoma japonicum cathepsin D aspartic protease. Parasite Immunol 2002; 24: 363-367.
55. Liu SX, Song G, Xu Y et al. Immunization of mice with recombinant Sjc26GST induces a pronounced anti-fecundity effect after experimental infection with Chinese Schistosoma japonicum. Vaccine 1995; 13: 603-607.
56. Liu SX, Song G, Xu Y, Yang W & McManus DP. Anti-fecundity immunity induced in pigs vaccinated with recombinant Schistosoma japonicum 26 kDa glutathione-S-transferase. Parasite Immunol 1995; 17: 355-340.
57. Liu SX, Yongkang H, Guangchen S, Xing-song L, Yuxin X & McManus DP. Anti-fecundity immunity to Schistosoma japonicum induced in Chinese water buffaloes (Bos buffelus) after vaccination with recombinant 26 kDa glutathione-S-transferase (reSjc26GST). Vet Parasitol 1997; 69: 39-47.
58. He YK, Liu SX, Zhang XY et al. Field assessment of recombinant Schistosoma japonicum 26 kDa glutathione S-transferase in Chinese water buffaloes. Southeast Asian J Trop Med Pub Health 2003; 34: 473-479.
59. Zhu Y, Ren J, Harn DA et al. Protective immunity induced with 23 kDa membrane protein DNA vaccine of Schistosoma japonicum Chinese strain in infected C57BL/6 mice. Southeast Asian J Trop Med Public Health 2003; 34: 697-701.
60. Zhu Y, Si J, Harn DA et al. The protective immunity of a DNA vaccine encoding Schistosoma japonicum Chinese strain triosephosphate isomerase in infected BALB/C mice. Southeast Asian J Trop Med Public Health 2004; 35: 518-522.
61. Zhu Y, Ren J, Da'dara A et al. The protective effect of a Schistosoma japonicum Chinese strain 23 kDa plasmid DNA vaccine in pigs is enhanced with IL-12. Vaccine 2004; 23: 78-83.
62. Waine G, Yang W, Scott J, McManus DP & Kalinna B. DNA-based vaccination using Schistosoma japonicum (Asian blood-fluke) genes. Vaccine 1997; 15: 846-848.
63. Zhou S, Liu S, Song G, Xu Y & Sun W. Protective immunity induced by the full-length cDNA encoding paramyosin of Chinese Schistosoma japonicum. Vaccine 2000; 18: 3196-3204.
64. Gurunathan S, Klinman D, Seder R. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 2000; 18: 927-974.
65. Zhang Y, Taylor M, Gregoriadis G, McCrossan M & Bickle Q. Immunogenicity of plasmid DNA encoding the 62 kDa fragment of Schistosoma japonicum myosin. Vaccine 2000; 18: 2102-2109.
66. Waine G, Mazzer D & McManus DP. DNA immunization by intramuscular injection or gene gun induces specific IgG anti-bodies against a Schistosoma japonicum 22 kDa antigen, Sj22, when fused to the murine Ig K-chain secretory leader sequence. Parasite Immunol 1999; 21: 53-56.
67. Waine G, Alarcon J & McManus DP. Genetic immunization of mice with DNA encoding the 23 kDa transmembrane surface protein of Schistosoma japonicum (Sj23) induces antigen-specific immunoglobulin G antibodies. Parasite Immunol 1999; 21: 377-381.
68. Zhang Y, Taylor M, Johansen M & Bickle Q. Vaccination of mice with a cocktail DNA vaccine induces a Th1-type immune response and partial protection against Schistosoma japonicum infection. Vaccine 2001; 20: 724-730.
69. Shalaby KA, Yin L, Thakur A, Christen L, Niles EG & LoVerde PT. Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes. Vaccine 2003; 22: 130-136.
70. Da'Dara AA, Skelly PJ, Walker CM & Harn DA. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection. Parasite Immunol 2003; 25: 429-437.
71. Hu W, Yan Q, Shen DK et al. Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource. Nat Genet 2003; 35: 139-147.
72. Verjovski-Almeida S, DeMarco R, Martins EA et al. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat Genet 2003; 35: 148-157.
73. Coppel RL & Black CG. Parasite genomes. Int J Parasitol 2005; 35: 465-479.
74. Curwen RS, Ashton PD, Johnston DA & Wilson RA. The Schistosoma mansoni soluble proteome: a comparison across four life-cycle stages. Mol Biochem Parasitol 2004; 138: 57-66.
75. Cheng GF, Lin JJ, Feng XG et al. Proteomic analysis of differentially expressed proteins between the male and female worm of Schistosoma japonicum after pairing. Proteomics 2005; 5: 511-521.
76. van Balkom BW, van Gestel RA, Brouwers JF et al. Mass spectrometric analysis of the Schistosoma mansoni tegumental sub-proteome. J Proteome Res 2005; 4: 958-966.
77. Fitzpatrick JM, Johnston DA, Williams GW et al. An oligonucleotide microarray for transcriptome analysis of Schistosoma mansoni and its application/use to investigate gender-associated gene expression. Mol Biochem Parasitol 2005; 141: 1-13.
78. Fitzpatrick JM, Johansen MV, Johnston DA, Dunne DW & Hoffmann KF. Gender-associated gene expression in two related strains of Schistosoma japonicum. Mol Biochem Parasitol 2004; 136: 191-209.
79. Gobert GN, Moertel L & McManus DP. Microarrays: new tools to unravel the transcriptome of parasites. Parasitology, in press.
80. Donner A & Klar N. Design and Analysis of Cluster Randomised Trials in Health Research. London: Arnold; 2000.
81. Liu JM, Cai XZ, Lin JJ et al. Gene cloning, expression and vaccine testing of Schistosoma japonicum SjFABP. Parasite Immunol 2004; 26: 351-358.
82. Chen LY, Yi XY, Zeng XF, Zhang SK & McReynolds L. [Mucosal immunization of recombinant Schistosoma japonicum ferritin] [Article in Chinese]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2004; 22: 129-132.
83. Yan Y, Liu S, Song G, Xu Y & Dissous C. Characterization of a novel vaccine candidate and serine proteinase inhibitor from Schistosoma japonicum (Sj serpin). Vet Parasitol 2005; 131: 53-60.
84. Shi F, Zhang Y, Lin J et al. Field testing of Schistosoma japonicum DNA vaccines in cattle in China. Vaccine 2002; 20: 3629-3631.